Menu
Richard Manning
Richard Manning

Richard Manning

Managing Director

Dr. Richard Manning is a Managing Director at Intensity, LLC. He provides data-driven insights to help clients solve complex economic problems. He has experience conducting economic analyses in matters involving breach of contract, fraud, pricing, economic valuation, intellectual property, antitrust, patent infringement, and public policy. His areas of expertise include:

  • Economic Valuation and Damages
  • Breach of Contract and Fraud
  • Antitrust and Competition
  • Patent Infringement
  • Public Policy

Dr. Manning has testified in U.S. District Court, the Delaware Court of Chancery, and the International Chamber of Commerce; served as consulting expert; and prepared reports on various matters in the biopharmaceutical and healthcare industries. His career includes 14 years as an executive at multinational pharmaceutical companies. He led economic analysis and strategy development to shape practices related to emerging business concerns.

Examples of Dr. Manning’s work include:

| Economic analysis and strategy relative to challenges affecting pricing, reimbursement, and intellectual property protection in worldwide markets.

| Collaborating with outside academic economists to analyze critical issues including healthcare benefit design; healthcare system reform proposals; marketing and advertising; intellectual property protection; FDA regulatory reform, including biosimilars approval processes and safety; and new product R&D.

| Specializing in strategic partnerships, merger and acquisitions activity, economic valuation of early-stage companies, and other economic analyses for biopharmaceutical, medical device, financial, and healthcare clients.

Prior to joining Intensity, Dr. Manning was a Partner with Bates White, an economic consulting firm offering analysis and expert testimony services to law firms, Fortune 500 companies, and government agencies. Previously, Dr. Manning was Executive Director at Merck & Co., Inc., and he was Senior Director at Pfizer, Inc. Also, Dr. Manning was a Director in the Advisory Strategy Group at PricewaterhouseCoopers.

Dr. Manning was an economics professor at Brigham Young University and a visiting professor in the Graduate School of Business at the University of Chicago. As an academic, his teaching and research focused on price theory, the economic analysis of law, industrial organization, and government regulation economics.

Dr. Manning received his Ph.D. in Economics from the University of Chicago. He earned his B.A. in Economics from Brigham Young University.

The Team